FDA Approves AI System for Early Sepsis Detection, Reducing Mortality

Thumbnail Image

The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.

The FDA has approved an AI-based early warning system for sepsis, developed by Johns Hopkins University and commercialized by Bayesian Health. Integrated with electronic health records, the system detects sepsis hours before clinicians, reducing sepsis mortality by nearly 20% in U.S. hospitals.[AI generated]

Why's our monitor labelling this an incident or hazard?

The article explicitly mentions an AI system designed to detect sepsis earlier than clinicians can, which has been FDA-approved and is in use in multiple hospitals. The system's use has directly led to a significant reduction in sepsis mortality, which constitutes harm to health being mitigated. Since the AI system's deployment has directly led to improved health outcomes and prevented harm, this qualifies as an AI Incident under the definition of an event where AI use has directly led to harm (in this case, reduction of harm).[AI generated]
Industries
Healthcare, drugs, and biotechnology

Business function:
Monitoring and quality control

AI system task:
Forecasting/predictionEvent/anomaly detection


Articles about this incident or hazard